Valliance Asset Management Ltd - Q3 2023 holdings

$27.5 Million is the total value of Valliance Asset Management Ltd's 14 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .

 Value Shares↓ Weighting
 YS BIOPHARMA CO LTDordinary shares$1,285,740
-42.0%
1,607,1750.0%4.68%
-86.8%
 YS BIOPHARMA CO LTD*w exp 03/15/202$30,900
-12.3%
750,0000.0%0.11%
-80.1%
HHLAWS  HH&L ACQUISITION CO*w exp 02/04/202$11,320
+41.5%
400,0000.0%0.04%
-68.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-10-27
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HH&L ACQUISITION CO8Q4 2022100.0%
SUMMIT HEALTHCRE ACQUISTN CO7Q4 202255.2%
PINDUODUO INC4Q4 202155.8%
TAIWAN SEMICONDUCTOR MFG LTD3Q2 202363.9%
YS BIOPHARMA CO LTD3Q3 202335.4%
YS BIOPHARMA CO LTD3Q3 20230.6%
HH&L ACQUISITION CO3Q3 20230.1%
ALIBABA GROUP HLDG LTD2Q1 202354.4%
SEA LTD2Q3 202142.3%
NVIDIA CORPORATION2Q3 202323.0%

View Valliance Asset Management Ltd's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-01-31
13F-HR2023-10-27
13F-HR2023-07-26
13F-HR2023-05-10
13F-HR2023-02-07
13F-HR2022-11-09
13F-HR2022-08-10
13F-HR2022-04-25
13F-HR2022-01-28
13F-HR2021-10-27

View Valliance Asset Management Ltd's complete filings history.

Compare quarters

Export Valliance Asset Management Ltd's holdings